Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

HIV/AIDS

Methodology

Twenty-five years ago, the first case of AIDS in the United States was reported. According to the National Institute of Allergy and Infectious Disease, there have been more than 900,000 cases of AIDS reported in the US since 1981, and there may be as many as 950,000 people in the US with HIV, the virus that causes AIDS. The Centers for Disease Control’s statistics estimate that approximately 40,000 people contract HIV annually.

This month, Special Topics examines the literature in HIV/AIDS research over the past decade and over the past two years. The resulting database contains over 50,000 papers as identified by the search strategy outlined below. We present the top 20 papers from the past decade and the past two years as well, the top 20 authors, institutions, journals, and nations performing HIV/AIDS research.

Judging by the number of papers in the top 20 list, the big draw in HIV/AIDS research over the past decade has been HIV-1 entry cofactors and co-receptors. The biggest of these discoveries appears to be that of CCR5, with no less than seven papers on this chemokine receptor on our list. Chemokine receptors CCR3, CCR2b, and SDF-1 are also included on this list. Other topics making the top 20 list include HIV-1 dynamics in vivo, envelope glycoproteins, CD4(+) cell responses, morbidity and mortality in AIDS patients, and antiretroviral drug trials, such as indinavir, zidovudine, and lamivudine.

Two substantial areas of HIV/AIDS research stand out on the two-year papers list: coinfection of HIV and hepatitis C, and various aspects of the antiretroviral factor APOBEC3F. Other topics covered on the two-year list include treatment guidelines, new antiretroviral drug trials, coinfection with GB virus C, TRIM5-alpha’s potential role in restricting HIV-1 infection in monkeys, T-cell levels, RNA interference, using nucleic acid amplification to detect HIV-1 and hepatitis C in blood donors, and the possibility of vaccines using replication-incompetent adenovirus vectors.

Methodology

To construct this database, papers were extracted based on title-supplied keywords for HIV/AIDS. The keywords used were as follows: 

HIV*
-or-
AIDS
-or-
human immunodeficiency virus*
-or_
acquired immune deficiency syndrome

The baseline time span for this database is 1996-February 28, 2006 (first bimonthly period of 2006). The resulting database contained 50,012 (10 years) and 10,519  (2 years) papers; 105,405 authors; 172 countries; 3,239 journals; and 16,873 institutions.

Rankings

Once the database was in place, it was used to generate the lists of top 20 papers (two- and ten-year periods), authors, journals, institutions, and nations, covering a time span of 1996-February 28, 2006 (a 10-year plus 2-month period).

The top 20 papers are ranked according to total cites. Rankings for author, journal, institution, and country are listed in three ways: according to total cites, total papers, and total cites/paper. The paper thresholds and corresponding percentages used to determine scientist, institution, country, and journal rankings according to total cites/paper, and total papers respectively are as follows:

Entity: Scientists Institutions Countries Journals
Thresholds: 37 121 18 32
Percentage: 1% 1% 50% 10%

Return to previous page

•> Search Special Topics
HIV/AIDS Menu
|| All Topics Menu

Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.